PKU GOLIKE
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PKU GOLIKE, covering 2025-06-08 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU. [NA]